-+ 0.00%
-+ 0.00%
-+ 0.00%

Cizzle Biotechnology Unit Partners with US Healthcare Services Group for Lung Cancer Tests

MT Newswires·08/03/2026 08:35:34
Listen to the news
08:35 AM EDT, 08/03/2026 (MT Newswires) -- Cizzle Biotechnology Holdings' (CIZ.L) Cizzle Bio signed an agreement with US-based healthcare services organization BioBridge Global to support the rollout of its CIZ1B biomarker blood test for lung cancer. BioBridge's BBG Advanced Therapies subsidiary will offer the test to licensed healthcare providers across South Texas, the US, once it secures the relevant certification as a laboratory partner, according to a Monday release. The commercial agreement executed by the early-stage cancer diagnostic tests company's North American licensing partner, its second with a clinical laboratory group, aims to accelerate the sales of the tests in the US.